Amyloidosis is a group of conditions that cause an abnormal protein called amyloid to build up in the body. Treatment depends on the type of amyloidosis but may include medications and organ ...

AL amyloidosis is associated with a clonal plasma cell dyscrasia and is caused by abnormal or excessive production of amyloidogenic immunoglobulin light chains, which aggregate into oligomers and ...

In this exclusive MedPage Today video, investigator Shahzad Raza, MD, of the Cleveland Clinic Cancer Institute, explains why ...

LECT2 amyloidosis (ALECT2) is a rare subtype of the disease that was discovered in 2007. It is not thought to be a hereditary subtype of amyloidosis, and it usually affects the kidneys. Learn more.

Amyloidosis is a condition that affects various body tissues and organs. Learn 8 ways it affects the body, and what you can do to manage these symptoms.

Multiple myeloma and amyloidosis begin the same way – in plasma cells, white blood cells that help your immune system. But multiple myeloma (MM) is a rare blood cancer while amyloidosis is a ...

In May, the company announced the failure of the monoclonal antibody birtamimab to improve mortality in a phase 3 trial of ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has recently completed a clinical study titled ...

Amyloidosis occurs when the proteins in the body become sticky and begin to clump together, Sperry says. In the brain, there's a type of amyloidosis that people know as Alzheimer’s disease.

Alnylam Pharmaceuticals, Inc. ALNY announced that the European Commission (EC) has approved a label expansion of its RNAi therapeutic Amvuttra.The EC has now approved Amvuttra for the treatment of ...

Cardiac amyloidosis portends a poor prognosis, with a median survival less than 6 months without treatment. However, if it is recognized early, there are specific treatments available.

Wainua is an injectable medicine. Here’s how it treats hereditary transthyretin-mediated amyloidosis (hATTR).